Stephen F. Traynelis, PhD, is a professor in the Department of Pharmacology and Chemical Biology at Emory University School of Medicine.
Dr. Traynelis is a member of the Discovery and Developmental Therapeutics Research Program at Winship Cancer Institute of Emory University.
Education
Dr. Traynelis earned his PhD from University of North Carolina at Chapel Hill in North Carolina.
Titles & Roles
Professor, Department of Pharmacology and Chemical Biology
Emory University School of Medicine
Research
Dr. Traynelis’ studies the basic mechanisms underlying excitatory synaptic transmission. His main focus has been on the postsynaptic glutamate receptor, which are ligand-gated ion channels that catalyze the transmembrane flux of cations in response to activation by the neurotransmitter glutamate. Ongoing experiments use electrophysiological approaches and molecular techniques to probe in detail the nature of glutamate receptor structure and function.
Publications
Dr. Traynelis is an author on over 200 peer-reviewed publications and is co-inventor on 7 US patents. He is former editor-in-chief of Molecular Pharmacology.
J Teoh, J Simko, CR Camp, CJ Liu, W Wang, D Williams, L Ma, D Soundararajan, C Martin, NK Taylor, E François, S Petri, A Kanber, A Ravichandra, ME Pero, F Bartolini, TC Swayne, CM Lutz, A Zuberi, M Rubinstein, M Hausman Kedem, H Yuan, JN Gelinas, TT Sands, SQ Harper, SF Traynelis, CD Makinson, WN Frankel
R Song, J Zhang, RE Perszyk, CR Camp, W Tang, V Kannan, J Li, Y Xu, J Chen, Y Li, SH Liang, SF Traynelis, H Yuan
12/01/2024
Awards
Dr. Traynelis is a John Merck Scholar, an AAAS Fellow, an ASPET fellow, as well as recipient of an NIH Javits Award, a R35 Research Program Award, and the Hodgkin-Huxley-Katz Prize from the British Physiological Society.
